Top ▲

complement C1s

Click here for help

Immunopharmacology Ligand  Target has curated data in GtoImmuPdb

Target id: 2335

Nomenclature: complement C1s

Family: S1: Chymotrypsin

Annotation status:  image of a red circle Awaiting annotation  » Email us

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 688 12p13.31 C1S complement C1s
Mouse - 688 6 F2 C1s2 complement component 1, s subcomponent 2
Rat - 688 4q42 C1s complement C1s
Previous and Unofficial Names Click here for help
C1sb | complement component C1SB | r-gsp | Gm5077 | predicted gene 5077 | complement component 1 | complement component 1, s subcomponent 2
Database Links Click here for help
Specialist databases
MEROPS S01.193 (Hs)
Other databases
Alphafold
BRENDA
CATH/Gene3D
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
KEGG Gene
OMIM
Orphanet
Pharos
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Enzyme Reaction Click here for help
EC Number: 3.4.21.42

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
compound 28 [PMID: 16460935] Small molecule or natural product Primary target of this compound Hs Inhibition 8.0 pKi 3
⤷ pKi 8.0 (Ki 1x10-8 M) [3]
Antibodies
Key to terms and symbols Click column headers to sort
Antibody Sp. Action Value Parameter Reference
claseprubart Peptide Immunopharmacology Ligand Hs Binding 11.0 pKd 1
⤷ pKd 11.0 (Kd 1x10-11 M) [1]
Description: Binding affinity for human active C1s determined by SPR
sutimlimab Peptide Approved drug Primary target of this compound Immunopharmacology Ligand Hs Binding 9.4 – 9.6 pKd 1-2
⤷ pKd 9.6 (Kd 2.6x10-10 M) [2]
Description: Binding affinity for human active C1s determined by SPR
pKd 9.4 (Kd 4x10-10 M) [1]
Description: Binding affinity for human pro-C1s determined by SPR
Antibody Comments
Sutimlimab (TNT009) binds to pro-C1s and mature C1s with the same affinity [2]. In contrast claseprubart (DNTH103 ) is selective for active C1s with low affinity for circulating pro-C1s.
Immunopharmacology Comments
A protease component of the C1-complex of the classical complement pathway.
Immuno Process Associations
Immuno Process:  B cell (activation)
GO Annotations:  Associated to 1 GO processes
GO:0006958 complement activation, classical pathway IDA
Immuno Process:  Immune regulation
GO Annotations:  Associated to 1 GO processes
GO:0006958 complement activation, classical pathway IDA
Immuno Process:  T cell (activation)
GO Annotations:  Associated to 1 GO processes
GO:0006958 complement activation, classical pathway IDA
Clinically-Relevant Mutations and Pathophysiology Click here for help
Disease:  Complement component C1s deficiency
Synonyms: Immunodeficiency due to an early component of complement deficiency [Orphanet: ORPHA169147]
OMIM: 613783
Orphanet: ORPHA169147

References

Show »

1. Bedian V, Omer CA. (2024) Antibodies that bind to cis and uses thereof. Patent number: US12110344B2. Assignee: Dianthus Therapeutics Opco Inc. Priority date: 21/11/2023. Publication date: 08/10/2024.

2. Panicker S, Parry G. (2016) Humanized anti-c1s antibodies and methods of use thereof. Patent number: WO2016164358A1. Assignee: True North Therapeutics, Inc.. Priority date: 06/04/2015. Publication date: 05/04/2016.

3. Subasinghe NL, Travins JM, Ali F, Huang H, Ballentine SK, Marugán JJ, Khalil E, Hufnagel HR, Bone RF, DesJarlais RL et al.. (2006) A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorg Med Chem Lett, 16 (8): 2200-4. [PMID:16460935]

How to cite this target page

S1: Chymotrypsin: complement C1s. Last modified on 06/07/2026. Accessed on 17/11/2026. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2335.